Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation

PHASE2CompletedINTERVENTIONAL
Enrollment

475

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

April 9, 2022

Study Completion Date

March 9, 2023

Conditions
Covid19Mechanical Ventilation ComplicationCorona Virus InfectionRespiratory FailureSARS (Severe Acute Respiratory Syndrome)
Interventions
BIOLOGICAL

Convalescent Plasma

2 units of convalescent plasma

OTHER

Standard of Care

Gold Standards

Trial Locations (17)

1000

CHU Saint Pierre, Brussels

1070

Erasme, Brussels

1090

UZ Brussel, Brussels

1200

UC Louvain, Leuven

1340

Clinique Saint Pierre Ottignies, Ottignies

2650

UZ Antwerpen, Antwerp

2820

Imelda ZH Bonheiden, Bonheiden

4000

CHR Citadelle, Liège

CHU Liège, Liège

5530

CHU UCL Namur-Godinne, Yvoir

6042

CHU Charleroi Marie Curie, Charleroi

7500

Centre Hospitalier Wallonie Picarde, Tournai

8500

AZ Groeningen Kortrijck, Kortrijk

8800

AZ Delta, Roeselare

9000

UZ Gent, Ghent

9200

AZ Sint Blasius, Dendermonde

9300

OLVZ Aalst, Aalst

All Listed Sponsors
collaborator

KCE Belgian Healthcare Knowledge Centre

UNKNOWN

lead

University of Liege

OTHER

NCT04558476 - Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation | Biotech Hunter | Biotech Hunter